Key facts
- OhMD’s last known valuation is $27.0M.
- It has raised $8.7M; the latest was Seed Round ($1.1M) in Jul 2024.
- Notable investors include Ben Uretsky, Blueprint Health, Chris Scott, Dudley Fund, Eideard Venture Capital — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for OhMD
- ·The full record, as it builds
Funding rounds
No funding rounds for OhMD are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About OhMD
Developer of a conversational artificial intelligence platform designed to automate routine patient phone calls for physician practices and call centers. The company offers voice and text AI for patient self-scheduling, alongside a leading two-way patient texting capability and API, enabling healthcare providers to increase appointment bookings, reduce office staffing costs, and improve the patient experience by eliminating hold times and phone tag.
- Sector
- Healthcare
- HQ
- Burlington, VT, United States
- Founded
- 2014
- Employees
- 40
- Website
- ohmd.com/
- Ownership
- Privately Held (backing)
OhMD doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in OhMD shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on OhMD in its N-PORT filings yet. We sweep new filings monthly.